Andrew Vakulin1, Peter G Catcheside2, Stuart D Baulk3, Nick A Antic2, Siobhan Banks4, Jillian Dorrian4, R Doug McEvoy2. 1. Adelaide Institute for Sleep Health, Repatriation General Hospital, Daws Road, Daw Park, Adelaide, Australia ; Sleep and Circadian Research Group and NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS), Woolcock Institute of Medical Research, Central Clinical School, University of Sydney, Australia ; Department of Medicine, Flinders University, Bedford Park, South Australia, Australia. 2. Adelaide Institute for Sleep Health, Repatriation General Hospital, Daws Road, Daw Park, Adelaide, Australia ; Department of Medicine, Flinders University, Bedford Park, South Australia, Australia. 3. Adelaide Institute for Sleep Health, Repatriation General Hospital, Daws Road, Daw Park, Adelaide, Australia ; The Appleton Institute, Central Queensland University, Adelaide, Australia. 4. Centre for Sleep Research, University of South Australia, City East Campus, Adelaide, Australia.
Abstract
STUDY OBJECTIVES: Obstructive sleep apnea (OSA) is associated with driving impairment and road crashes. However, daytime function varies widely between patients presenting a clinical challenge when assessing crash risk. This study aimed to determine the proportion of patients showing "normal" versus "abnormal" driving simulator performance and examine whether anthropometric, clinical, and neurobehavioral measures predict abnormal driving. METHODS: Thirty-eight OSA patients performed a 90-min simulated driving task under 3 conditions: normal sleep, restricted sleep (4 h in bed), and normal sleep + alcohol (BAC∼0.05 g/dL). Patients were classified as "resilient" drivers if, under all 3 experimental conditions their mean steering deviation fell within 2 standard deviations of the mean steering deviation of 20 controls driving under baseline normal sleep conditions, or a "vulnerable" driver if mean steering deviation was outside this range in at least one experimental condition. Potentially predictive baseline anthropometric, clinical, neurocognitive, and cortical activation measures were examined. RESULTS: Of the 38 OSA patients examined, 23 (61%) and 15 (39%) were classified as resilient and vulnerable drivers, respectively. There were no differences in baseline measures between the groups, although the proportion of females was greater and self-reported weekly driving exposure was less among vulnerable drivers (p < 0.05). On univariate analysis gender, weekly driving hours, and auditory event related potential P2 amplitude were weakly associated with group status. Multivariate analysis showed weekly driving hours (OR 0.69, 95%CI, 0.51-0.94, p = 0.02) and P2 amplitude (OR 1.34, 95%CI 1.02-1.76, p = 0.035) independently predicted vulnerable drivers. CONCLUSIONS: Most OSA patients demonstrated normal simulated driving performance despite exposure to further sleep loss or alcohol. Most baseline measures did not differentiate between resilient and vulnerable drivers, although prior driving experience and cortical function were predictive. Novel measures to assist identification of OSA patients at risk of driving impairment and possibly accidents are needed. TRIAL REGISTRATION: Data presented in this manuscript was collected as part of a clinical trial "Experimental Investigations of Driving Impairment in Obstructive Sleep Apnea." Trial ID: ACTRN12610000009011, URL: http://www.anzctr.org.au/trial_view.aspx?ID=334979.
STUDY OBJECTIVES:Obstructive sleep apnea (OSA) is associated with driving impairment and road crashes. However, daytime function varies widely between patients presenting a clinical challenge when assessing crash risk. This study aimed to determine the proportion of patients showing "normal" versus "abnormal" driving simulator performance and examine whether anthropometric, clinical, and neurobehavioral measures predict abnormal driving. METHODS: Thirty-eight OSA patients performed a 90-min simulated driving task under 3 conditions: normal sleep, restricted sleep (4 h in bed), and normal sleep + alcohol (BAC∼0.05 g/dL). Patients were classified as "resilient" drivers if, under all 3 experimental conditions their mean steering deviation fell within 2 standard deviations of the mean steering deviation of 20 controls driving under baseline normal sleep conditions, or a "vulnerable" driver if mean steering deviation was outside this range in at least one experimental condition. Potentially predictive baseline anthropometric, clinical, neurocognitive, and cortical activation measures were examined. RESULTS: Of the 38 OSA patients examined, 23 (61%) and 15 (39%) were classified as resilient and vulnerable drivers, respectively. There were no differences in baseline measures between the groups, although the proportion of females was greater and self-reported weekly driving exposure was less among vulnerable drivers (p < 0.05). On univariate analysis gender, weekly driving hours, and auditory event related potential P2 amplitude were weakly associated with group status. Multivariate analysis showed weekly driving hours (OR 0.69, 95%CI, 0.51-0.94, p = 0.02) and P2 amplitude (OR 1.34, 95%CI 1.02-1.76, p = 0.035) independently predicted vulnerable drivers. CONCLUSIONS: Most OSA patients demonstrated normal simulated driving performance despite exposure to further sleep loss or alcohol. Most baseline measures did not differentiate between resilient and vulnerable drivers, although prior driving experience and cortical function were predictive. Novel measures to assist identification of OSA patients at risk of driving impairment and possibly accidents are needed. TRIAL REGISTRATION: Data presented in this manuscript was collected as part of a clinical trial "Experimental Investigations of Driving Impairment in Obstructive Sleep Apnea." Trial ID: ACTRN12610000009011, URL: http://www.anzctr.org.au/trial_view.aspx?ID=334979.
Authors: Danny J Eckert; Peter G Catcheside; Rachel McDonald; Amanda M Adams; Kate E Webster; Michael C Hlavac; R Doug McEvoy Journal: Am J Respir Crit Care Med Date: 2005-06-23 Impact factor: 21.405
Authors: M Orth; H-W Duchna; M Leidag; W Widdig; K Rasche; T T Bauer; J W Walther; J de Zeeuw; J-P Malin; G Schultze-Werninghaus; S Kotterba Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: Jennifer M Cori; Melinda L Jackson; Maree Barnes; Justine Westlake; Paul Emerson; Jacen Lee; Rosa Galante; Amie Hayley; Nicholas Wilsmore; Gerard A Kennedy; Mark Howard Journal: J Clin Sleep Med Date: 2018-06-15 Impact factor: 4.062
Authors: Jesse L Parker; Sarah L Appleton; Yohannes Adama Melaku; Angela L D'Rozario; Gary A Wittert; Sean A Martin; Barbara Toson; Peter G Catcheside; Bastien Lechat; Alison J Teare; Robert J Adams; Andrew Vakulin Journal: J Clin Sleep Med Date: 2022-06-01 Impact factor: 4.324
Authors: Sarah M Jay; Bradley P Smith; Samantha Windler; Jillian Dorrian; Sally A Ferguson Journal: Int J Environ Res Public Health Date: 2016-01-29 Impact factor: 3.390
Authors: Sergio Garbarino; Paola Lanteri; Paolo Durando; Nicola Magnavita; Walter G Sannita Journal: Int J Environ Res Public Health Date: 2016-08-18 Impact factor: 3.390